Protocol No.: A012301

LOTAM: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early Stage Breast Cancer
Principal Investigator
Jiang, Bei
Phase
III
Age Group
Adult
Applicable Disease Site
Breast Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Melissa Boggess, RN
Research Nurse
Phone: +1 304-487-7515
Maher Kali, MD
Clinical Research Specialist-WVUCI
Phone: +1 304-243-7045
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Kaitlyn Hager
Research Nurse

View on ClinicalTrials.gov